Mariette C, Fabre S, Balon J M, Finzi L, Chevalier D, Triboulet J P
Service de chirurgie digestive et générale, hôpital Claude-Huriez, CHRU, place de Verdun, 59037 Lille cedex, France.
Ann Chir. 2002 Dec;127(10):757-64. doi: 10.1016/s0003-3944(02)00893-3.
To determine therapeutic and prognostic implications of an associated head and neck primary cancer in patients undergoing oesophagectomy for squamous cell carcinoma of the oesophagus.
Between 1982 and 2000, 868 patients with oesophageal cancer were operated in our institution, including 78 (9%) who underwent oesophagectomy for associated oesophageal and head and neck cancers; the latter was synchronous (n = 52) or anterior metachronous (n = 26). Influence of head and neck cancer on the treatment of oesophageal carcinoma was analysed retrospectively in terms of surgical therapeutic strategy and survival.
Oesophageal resection consisted of oeso-pharyngolaryngectomy (n = 14, 17.9%), subtotal oesophagectomy (n = 62, 79.5%) and cervical oesophagectomy (n = 2, 2.6%). Radical resection (R0) was obtained in 85% of cases. Postoperative mortality rate was 5 % (4/78). Main complications were pulmonary (18% = 14/78) and anastomotic leaks (14% = 11/78), all of them cervical. Follow-up (mean = 25 +/- 27 months) was complete for all 78 patients. Five-year survival after R0 resection was 25%. Survival pronostic factors were denutrition, complete resection, and pT status of oesophageal tumor.
In patients with associated carcinomas of oesophagus and head and neck, agressive treatment -including an oesophagectomy- allowed a 5-year survival rate more than 25% without increased mortality or morbidity rates, compared with patients operated on for isolated oesophageal carcinoma.
确定在因食管鳞状细胞癌接受食管切除术的患者中,合并头颈部原发性癌症的治疗及预后意义。
1982年至2000年间,我院对868例食管癌患者进行了手术,其中78例(9%)因合并食管癌及头颈部癌症接受了食管切除术;后者为同步癌(n = 52)或先期异时癌(n = 26)。从手术治疗策略和生存率方面对合并头颈部癌症对食管癌治疗的影响进行了回顾性分析。
食管切除术包括食管 - 咽喉切除术(n = 14,17.9%)、次全食管切除术(n = 62,79.5%)和颈部食管切除术(n = 2,2.6%)。85%的病例实现了根治性切除(R0)。术后死亡率为5%(4/78)。主要并发症为肺部并发症(18% = 14/78)和吻合口漏(14% = 11/78),均发生在颈部。78例患者均完成随访(平均 = 25 ± 27个月)。R0切除术后的5年生存率为25%。生存预后因素为营养不良、完全切除以及食管肿瘤的pT分期。
与单纯食管癌手术患者相比,对于合并食管癌及头颈部癌症的患者,积极治疗(包括食管切除术)可使5年生存率超过25%,且不增加死亡率或发病率。